Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary proteins in the gastrointestinal lumen represent the pool of ingested macronutrients undergoing mechanical and chemical breakdown to provide essential amino acids (StatPearls, NBK544242). The digestion process begins in the stomach with pepsin and continues in the small intestine through the action of pancreatic proteases like trypsin and chymotrypsin (Guyton and Hall, Textbook of Medical Physiology). In certain pathological states, such as Celiac disease, specific dietary proteins like gluten act as triggers for autoimmune destruction of the intestinal mucosa (NIDDK, Celiac Disease). In cases of exocrine pancreatic insufficiency, the inability to digest these proteins leads to malabsorption and malnutrition (Mayo Clinic, Pancreatic Insufficiency). Therapeutic interventions often target the digestion of these proteins, using exogenous enzymes like pancrelipase to restore function (FDA, Creon Label). Additionally, novel therapies like latiglutenase aim to degrade specific immunogenic protein fragments within the lumen to prevent disease flares (Gastroenterology, 2014). Monitoring the effective breakdown and absorption of these proteins is critical in managing gastrointestinal and metabolic health.
Therapeutic agents typically involve the enzymatic hydrolysis of peptide bonds to facilitate absorption in cases of deficiency or to neutralize immunogenic sequences in hypersensitivity disorders (StatPearls, NBK544242).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary proteins in the gastrointestinal lumen.